eXmoor and Signadori Bio enter cell therapy partnership
Signadori is advancing a platform designed to overcome the challenges of treating solid cancers
Read More
Tag: solid tumours
invoX Pharma’s FS222 delivers encouraging solid tumour treatment results
Positive clinical data from phase 1 study presented at ASCO annual meeting
Read More
Iksuda signs licence agreement with Femtogenix for solid tumours
Iksuda Therapeutics and Femtogenix have signed a licensing agreement for antibody-drug conjugates.
Read More
Bicycle, CR UK launch first trial of a bicyclic peptide
Bicycle Therapeutics and Cancer Research UK have initiated the first clinical study to assess a bicyclic peptide, evaluating its potential in patients with advanced solid tumours.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
